# 244 - 5 Critical Quality Differences Between Drugs and Devices

Page: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/244-5-critical-quality-differences-between-drugs-and-devices
Text version: https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/244-5-critical-quality-differences-between-drugs-and-devices.md
Podcast: [Let's Combinate - Drugs + Devices](https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248)
Published: 2026-07-01T10:00:00+00:00
Episode link: https://podcasters.spotify.com/pod/show/letscombinate/episodes/244---5-Critical-Quality-Differences-Between-Drugs-and-Devices-e3lg88e
Audio file: https://anchor.fm/s/6770b9a0/podcast/play/122216142/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-5-30%2F427127123-44100-2-c05d145022773.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/244-5-critical-quality-differences-between-drugs-and-devices
Duration seconds: 529

## Resource

Download the free Drug vs. Device Quality comparison guide here: https://letscombinate.kit.com/216fbfc6c2 In this Let’s Combinate episode, Subhi explains why drug and device quality are not the same and highlights five key areas where they differ for combination products. Drug quality often focuses on consistently remaking the product that was proven clinically, using critical quality attributes, specifications, analytical methods, stability, process validation, and batch release. Device quality emphasizes design robustness and intended use through design controls and product realization, from user needs and design inputs to validation and design transfer. This episode covers five major differences: Quality philosophy and evidence Development approach Risk management Regulatory submission focus Lifecycle management and change control The goal is not to force one system onto the other. The goal is to understand the differences early enough to intentionally integrate drug and device quality across development, manufacturing, regulatory strategy, and lifecycle management. Chapters 00:00 Drugs vs. Devices: Why Quality Differs 00:20 Intro and Practical Guide 00:50 Quality Philosophy and Evidence 02:27 Development Approach Differences 03:56 Risk Management Mindsets 05:48 Regulatory Submission Focus 06:23 Lifecycle and Change Control 08:03 Summary and Next Steps Subhi Saadeh is a quality professional, consultant, auditor, and trainer who specializes in drug-device combination products, medical devices, pharmaceutical quality systems, supplier quality, and lifecycle management. Through Let’s Combinate, he helps pharmaceutical and medical device teams bridge the gap between drug and device quality, regulatory expectations, and practical execution.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/let-s-combinate-drugs-devices-4474248/episodes/244-5-critical-quality-differences-between-drugs-and-devices/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/let-s-combinate-drugs-devices-4474248/244-5-critical-quality-differences-between-drugs-and-devices.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.